Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2

Neuroreport. 1997 Sep 29;8(14):3131-5. doi: 10.1097/00001756-199709290-00025.

Abstract

Two highly-selective mu-opioid receptor agonists, endomorphin-1 and -2, were recently purified from bovine brain and are postulated to be endogenous mu-opioid receptor ligands. We sought to determine the effects of these ligands at the spinal level in mice. Endomorphin-1 and -2 produced short acting, naloxone-sensitive antinociception in the tail flick test and inhibited the behavior elicited by intrathecally injected substance P. Both endomorphin-1 and -2 were anti-allodynic in the dynorphin-induced allodynia model. Although acute tolerance against both endomorphins developed rapidly, endomorphin-1 required a longer pretreatment time before tolerance was observed. We conclude that the endomorphins are potent spinal antinociceptive and anti-allodynic agents and that they or related compounds may prove therapeutically useful as spinal analgesics.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Animals
  • Cattle
  • Drug Tolerance
  • Hot Temperature
  • Injections, Spinal
  • Male
  • Mice
  • Mice, Inbred ICR
  • Oligopeptides / pharmacology*
  • Receptors, Opioid, mu / agonists*
  • Substance P / antagonists & inhibitors

Substances

  • Analgesics, Opioid
  • Oligopeptides
  • Receptors, Opioid, mu
  • endomorphin 1
  • Substance P
  • endomorphin 2